scispace - formally typeset
J

Jie Niu

Researcher at Zhejiang University

Publications -  12
Citations -  583

Jie Niu is an academic researcher from Zhejiang University. The author has contributed to research in topics: Gene delivery & Transdermal. The author has an hindex of 9, co-authored 12 publications receiving 372 citations.

Papers
More filters
Journal ArticleDOI

Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity.

TL;DR: The synthesis of antimicrobial peptide conjugated cationic AuNPs (AuNPs@PEP) as highly efficient carriers for gene delivery to stem cells with antibacterial ability is reported, suggesting its potential as a multifunctional system with both gene delivery and antibacterial abilities in clinic.
Journal ArticleDOI

TAT conjugated cationic noble metal nanoparticles for gene delivery to epidermal stem cells.

TL;DR: The synthesis of the TAT peptide conjugated cationic noble metal nanoparticles (metal NPs@PEI-TAT) are reported as highly efficient carriers for gene delivery to stem cells and enhance their directed differentiation for biomedical application.
Journal ArticleDOI

Transdermal Gene Delivery by Functional Peptide-Conjugated Cationic Gold Nanoparticle Reverses the Progression and Metastasis of Cutaneous Melanoma.

TL;DR: Evidence is provided that penetrating peptide conjugated cationic gold nanoparticle offers a promising vehicle for both the skin penetration and transfection of pDNAs, possessing great potential in topical gene therapy.
Journal ArticleDOI

Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL–programmed therapy against melanoma

TL;DR: I-P-OMVs are the first nanoplatforms to induce transdermal photo-TRAIL–programmed therapy in melanoma with enhanced antitumor performance and high safety, having great potential in cancer therapy.
Journal ArticleDOI

Transdermal siRNA delivery by pH-switchable micelles with targeting effect suppress skin melanoma progression.

TL;DR: This study provides a proof-of-concept design of pH-switchable cationic micelles as transdermal gene delivery nanoplatforms with targeting effect for melanoma therapy, which may be adapted widely in the treatment of various superficial tumors and skin genetic diseases.